S D'Iddio

772 total citations
22 papers, 506 citations indexed

About

S D'Iddio is a scholar working on Clinical Biochemistry, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, S D'Iddio has authored 22 papers receiving a total of 506 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Clinical Biochemistry, 7 papers in Molecular Biology and 7 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in S D'Iddio's work include Metabolism and Genetic Disorders (18 papers), Mitochondrial Function and Pathology (7 papers) and Neurological and metabolic disorders (7 papers). S D'Iddio is often cited by papers focused on Metabolism and Genetic Disorders (18 papers), Mitochondrial Function and Pathology (7 papers) and Neurological and metabolic disorders (7 papers). S D'Iddio collaborates with scholars based in Italy, Switzerland and Spain. S D'Iddio's co-authors include Menotti Calvani, Paola Benatti, Joaquı́n Arenas, Angelo Mancinelli, Massimo Zeviani, Massimiliano Marco Corsi Romanelli, P. Pola, José Ramón Ricoy, Stefano DiDonato and D. Reina and has published in prestigious journals such as PLoS ONE, Biochemical and Biophysical Research Communications and Annals of the New York Academy of Sciences.

In The Last Decade

S D'Iddio

22 papers receiving 484 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S D'Iddio Italy 13 299 171 141 84 76 22 506
J. E. Fischer United States 11 72 0.2× 189 1.1× 76 0.5× 63 0.8× 23 0.3× 20 508
M. J. Stevens United States 8 88 0.3× 89 0.5× 300 2.1× 79 0.9× 24 0.3× 9 524
Elif Özkök Türkiye 14 79 0.3× 137 0.8× 52 0.4× 9 0.1× 30 0.4× 39 488
Manuel Nava Venezuela 13 39 0.1× 131 0.8× 120 0.9× 16 0.2× 23 0.3× 27 489
Masaharu OHNAKA Japan 10 20 0.1× 119 0.7× 298 2.1× 152 1.8× 52 0.7× 23 581
Akinori Kogure Japan 14 52 0.2× 128 0.7× 341 2.4× 69 0.8× 15 0.2× 26 589
Kathleen M. Randolph United States 12 43 0.1× 284 1.7× 182 1.3× 86 1.0× 34 0.4× 25 534
Nicholas G. Norwitz United States 16 53 0.2× 143 0.8× 429 3.0× 43 0.5× 24 0.3× 35 628
Roberta Machado Brazil 11 31 0.1× 126 0.7× 90 0.6× 12 0.1× 79 1.0× 14 518
Hongbin Sun China 10 75 0.3× 45 0.3× 145 1.0× 9 0.1× 79 1.0× 28 370

Countries citing papers authored by S D'Iddio

Since Specialization
Citations

This map shows the geographic impact of S D'Iddio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S D'Iddio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S D'Iddio more than expected).

Fields of papers citing papers by S D'Iddio

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S D'Iddio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S D'Iddio. The network helps show where S D'Iddio may publish in the future.

Co-authorship network of co-authors of S D'Iddio

This figure shows the co-authorship network connecting the top 25 collaborators of S D'Iddio. A scholar is included among the top collaborators of S D'Iddio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S D'Iddio. S D'Iddio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schaevitz, Laura, et al.. (2012). Acetyl-L-Carnitine Improves Behavior and Dendritic Morphology in a Mouse Model of Rett Syndrome. PLoS ONE. 7(12). e51586–e51586. 26 indexed citations
2.
Martinotti, Giovanni, D. Reina, Marco Di Nicola, et al.. (2011). Acetyl-l-Carnitine in the treatment of anhedonia, melancholic and negative symptoms in alcohol dependent subjects. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 35(4). 953–958. 47 indexed citations
3.
Martinotti, Giovanni, D. Reina, Marco Di Nicola, et al.. (2010). Acetyl-L-Carnitine for Alcohol Craving and Relapse Prevention in Anhedonic Alcoholics: A Randomized, Double-Blind, Placebo-Controlled Pilot Trial. Alcohol and Alcoholism. 45(5). 449–455. 24 indexed citations
4.
Mancinelli, Angelo, S D'Iddio, Renato Bisonni, et al.. (2006). Urinary excretion of l-carnitine and its short-chain acetyl-l-carnitine in patients undergoing carboplatin treatment. Cancer Chemotherapy and Pharmacology. 60(1). 19–26. 19 indexed citations
5.
Calvani, Menotti, Paola Benatti, Angelo Mancinelli, et al.. (2004). Carnitine Replacement in End‐Stage Renal Disease and Hemodialysis. Annals of the New York Academy of Sciences. 1033(1). 52–66. 51 indexed citations
6.
Reda, Emilia, S D'Iddio, R. Nicolai, Paola Benatti, & Menotti Calvani. (2003). The carnitine system and body composition. Acta Diabetologica. 40(S1). s106–s113. 36 indexed citations
7.
Calvani, Menotti, S D'Iddio, Andrea De Gaetano, et al.. (2001). [L-acetylcarnitine treatment on fragile X patients hyperactive behaviour].. PubMed. 33 Suppl 1. S65–70. 4 indexed citations
8.
Marzo, A, et al.. (1994). Plasma concentration, urinary excretion and renal clearance of L-carnitine during pregnancy: a reversible secondary L-carnitine deficiency. Gynecological Endocrinology. 8(2). 115–120. 13 indexed citations
9.
Giovenali, Paolo, et al.. (1994). Selective trophic effect of L-carnitine in type I and IIa skeletal muscle fibers. Kidney International. 46(6). 1616–1619. 41 indexed citations
10.
Campos, Yolanda, et al.. (1992). Respiratory chain enzymes in muscle of endurance athletes: Effect of L-carnitine. Biochemical and Biophysical Research Communications. 188(1). 102–107. 35 indexed citations
11.
Gasparetto, A, et al.. (1991). Influence of acetyl-L-carnitine infusion on haemodynamic parameters and survival of circulatory-shock patients.. PubMed. 11(2). 83–92. 17 indexed citations
12.
Arenas, Joaquı́n, José Ramón Ricoy, P. Pola, et al.. (1991). Carnitine in muscle, serum, and urine of nonprofessional athletes: Effects of physical exercise, training, and L‐carnitine administration. Muscle & Nerve. 14(7). 598–604. 62 indexed citations
13.
Spagnoli, Luigi Giusto, et al.. (1990). Morphometric Evidence of the Trophic Effect of <i>L</i>-Carnitine on Human Skeletal Muscle. ˜The œNephron journals/Nephron journals. 55(1). 16–23. 39 indexed citations
14.
Bellinghieri, Guido, C. Barbera, Maria Grazia Egitto, et al.. (1990). <i>L</i>-Carnitine and Platelet Aggregation in Uremic Patients Subjected to Hemodialysis. ˜The œNephron journals/Nephron journals. 55(1). 28–32. 8 indexed citations
15.
Montanari, G, et al.. (1990). Metabolic effects induced by L-carnitine and propionyl-L-carnitine in human hypoxic muscle tissue during exercise.. PubMed. 10(3). 197–202. 11 indexed citations
16.
D'Iddio, S, et al.. (1989). <i>L</i>-Carnitine Addition to Dialysis Fluid. ˜The œNephron journals/Nephron journals. 51(2). 237–242. 9 indexed citations
17.
Segré, G, Enrica Bianchi, Marco Corsi, et al.. (1988). Plasma and urine pharmacokinetics of free and of short-chain carnitine after administration of carnitine in man.. PubMed. 38(12). 1830–4. 36 indexed citations
18.
Rocchi, Laura, et al.. (1986). Effects of carnitine administration in patients with chronic renal failure undergoing periodic dialysis, evaluated by computerized electromyography.. PubMed. 12(8). 707–11. 9 indexed citations
19.
D'Iddio, S, et al.. (1982). L-carnitine in haemodialysed patients. Changes in lipid pattern.. PubMed. 32(3). 293–7. 4 indexed citations
20.
Caruso, U., et al.. (1981). [Domperidone as an anti-emetic in antineoplastic chemotherapy].. PubMed. 36(11). 787–91. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026